Get the tools used by (smart)2 investors.

Common Equity for Insulet Corporation

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

PODD: Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...

- USD
Price
USD
Fair Value
Upside
- - -
52-week range

Analysis

How does Insulet's Common Equity benchmark against competitors?

Hide this widget

Metric Usage: Common Equity

Hide this widget
equity_common
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Common Equity in the financials category include:

  • Shares per Depository Receipt - ADR/GDR ratio for all companies that are deemed the ADR/GDR security as company primary (all non-primary ADR/GDR companies will be given a value = 1)
  • Gross Profit - Measure of the profitability of a company's core operations before accounting for other expenses such as overhead, taxes, and interest
  • Interest Expense - The costs incurred from non-operating borrowings for the given period.
  • Deferred Tax Liability, Long-term - A liability created by a difference between accounting for income tax purposes and financial reporting purposes.
View Full List

Search for metric or datapoint

Common Equity

Definition of Common Equity

Hide this widget

Insulet reported common equity of 1.212 B for the latest quarter ending December 31, 2024 on its balance sheet.

The tables below summarizes Insulet’s Common Equity and common size over the last five years:

Fiscal YearCommon EquityAssets% Assets
2020-12-31603.6 M1.873 B32.2%
2021-12-31556.3 M2.049 B27.2%
2022-12-31476.4 M2.251 B21.2%
2023-12-31732.7 M2.588 B28.3%
2024-12-311.212 B3.088 B39.2%

The tables below summarizes Insulet’s Common Equity and common size over the last four quarters:

Quarter EndingCommon EquityAssets% Assets
2024-03-31790.7 M2.624 B30.1%
2024-06-30998.4 M2.882 B34.6%
2024-09-301.118 B3.025 B37.0%
2024-12-311.212 B3.088 B39.2%

Click the link below to download a spreadsheet with an example Common Equity calculation for Insulet Corporation below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0 K3 B6 B10.984 B2006001,0001,400

The chart above depicts the distribution of common equity for companies operating in the Healthcare sector in the Developed economic region. Over 2,490 companies were considered in this analysis, and 2,396 had meaningful values. The average common equity of companies in the sector is 371.2 M with a standard deviation of 1.147 B.

Insulet Corporation's Common Equity of 1.212 B ranks in the 92.0% percentile for the sector. The following table provides additional summary stats:

Common Equity In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,496
Included Constituents2,396
Min-97.283 M
Max10.901 B
Median21.693 M
Mean371.2 M
Standard Deviation1.147 B

You can find companies with similar common equity using this stock screener.

All rights reserved. Terms Of Use